| General Information of Drug Metabolite (DM) (ID: DM004146) |
| DM Name |
BMS-488043 Metabolite M1
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A4 (CYP3A4)
|
DME0001
|
| Unclear - Unclear |
BMS-488043
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| BMS-488043 |
DR1781
|
Discontinued |
Human immunodeficiency virus infection |
|
|
| References |
| 1 |
Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic properties
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
